| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2850576 | American Heart Journal | 2009 | 10 Pages |
Abstract
TRA 2°P-TIMI 50 is evaluating whether a new approach to platelet inhibition via interruption of thrombin-mediated platelet activation reduces major cardiovascular events with a favorable safety profile in patients with established atherosclerosis.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
David A. MD, MPH, Benjamin M. MD, MPH, Keith A.A. MD, Gail MD, John MD, Enrico MD, Marc P. MD, Polly BA, Carolyn H. BS, Eugene MD, for the TRA 2°P-TIMI 50 Investigators for the TRA 2°P-TIMI 50 Investigators,